In2Bones announced today that it began the U.S. launch for its Avenger radial head prosthesis system for primary and revision joint replacement of the radial head.
The Memphis, Tenn.–based company’s new prosthesis is designed to restore elbow joint function and offer other advantages for both surgeons and patients when compared to the current prosthetic systems on the market, according to a news release. The company touts the Avenger system as the first radial head implant to include sterile, single-use instrumentation.
Avenger is designed to allow surgeons to restore the appropriate height of the radius to aid in elbow stability. It consists of a smooth stem, which In2Bones said has been proven to provide better clinical outcomes than press-fit, ingrowth radial head implant designs.
In2Bones said using the Avenger system could provide benefits such as cost savings of as much as $400 per surgery, increased efficiencies due to bypassed long lead times and sterilizing delays and the reduced risk of surgical site infections post-operatively.
“Currently, radial head implant suppliers ship non-sterile instrument sets nationwide for short-notice cases, which can cause potential delays and can increase costs,” In2Bones senior VP of marketing Jon Simon said in the news release. “The Avenger radial head system can be placed on shelves and be ready for immediate use, on-demand. Additionally, surgeons and caregivers can be assured that the sharp, precision instrumentation will only ever contact one patient.”